• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,25 - 二羟基维生素D3与生长激素疗法对生长激素缺乏症患儿血清骨钙素水平的影响

Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency.

作者信息

Antoniazzi F, Radetti G, Zamboni G, Gambaro G, Adami S, Tatò L

机构信息

Servizio Autonomo di Endocrinologia Pediatrica, University of Verona, Italy.

出版信息

Bone Miner. 1993 May;21(2):151-6. doi: 10.1016/s0169-6009(08)80017-7.

DOI:10.1016/s0169-6009(08)80017-7
PMID:8358252
Abstract

In order to investigate the influence on bone metabolism of growth hormone (GH), we evaluated the response to an acute load of 1,25(OH)2D3 (Rocaltrol) (1.5 micrograms/day for 4 days) in 16 growth hormone-deficient prepubertal children (11 boys and 5 girls, aged from 6.2 to 9.6 years) both before and after 1 month of human GH (hGH) therapy (0.1 IU/kg/day, 6 times per week). Before and after the 1,25(OH)2D3 load, serum IGF-I, osteocalcin, Ca, P, alkaline phosphatase (ALP) and urinary excretion of Ca and P were measured. The serum levels of osteocalcin rose significantly after the first 1,25(OH)2D3 load, without an increase in IGF-I values and with a slight non-significant increase in serum Ca and P. Almost superimposable increases of osteocalcin, Ca and P were observed after 1 month of hGH therapy, with a significant increase of IGF-I, but they did not rise further after the second 1,25(OH)2D3 load. On the basis of our results, 1,25(OH)2D3 seems to have a stimulatory action on osteoblastic activity even in the absence of normal levels of GH. However, there is no apparent additional stimulatory activity after administration of hGH. Osteocalcin level behaviour during our study might suggest that GH and 1,25(OH)2D3 have a common and easily saturable stimulatory pathway on osteoblastic function.

摘要

为了研究生长激素(GH)对骨代谢的影响,我们评估了16名青春期前生长激素缺乏儿童(11名男孩和5名女孩,年龄6.2至9.6岁)在接受1个月的人生长激素(hGH)治疗(0.1 IU/kg/天,每周6次)前后,对1,25(OH)2D3(罗钙全)急性负荷(1.5微克/天,共4天)的反应。在给予1,25(OH)2D3负荷前后,测量血清胰岛素样生长因子-I(IGF-I)、骨钙素、钙、磷、碱性磷酸酶(ALP)以及钙和磷的尿排泄量。首次给予1,25(OH)2D3负荷后,血清骨钙素水平显著升高,IGF-I值未增加,血清钙和磷略有非显著性升高。hGH治疗1个月后,观察到骨钙素、钙和磷几乎有叠加性升高,IGF-I显著增加,但第二次给予1,25(OH)2D3负荷后它们未进一步升高。根据我们的结果,即使在GH水平不正常的情况下,1,25(OH)2D3似乎对成骨细胞活性也有刺激作用。然而,给予hGH后没有明显的额外刺激活性。我们研究期间骨钙素水平的变化可能表明,GH和1,25(OH)2D3在成骨细胞功能上有共同且易于饱和的刺激途径。

相似文献

1
Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency.1,25 - 二羟基维生素D3与生长激素疗法对生长激素缺乏症患儿血清骨钙素水平的影响
Bone Miner. 1993 May;21(2):151-6. doi: 10.1016/s0169-6009(08)80017-7.
2
Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.用1,25 - 二羟基维生素D3、25 - 羟基维生素D3或24,25 - 二羟基维生素D3处理的大鼠的骨转换
Biosci Rep. 1993 Feb;13(1):27-39. doi: 10.1007/BF01138176.
3
Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.1,25 - 二羟基维生素D3对小鼠长骨中骨钙素生成和骨吸收的调节:与骨源性生长因子转化生长因子-β和胰岛素样生长因子-I的相互作用
J Bone Miner Res. 1998 Jan;13(1):36-43. doi: 10.1359/jbmr.1998.13.1.36.
4
Effect of growth hormone therapy on bone metabolism of growth hormone deficient children.生长激素治疗对生长激素缺乏儿童骨代谢的影响。
Eur J Pediatr. 1997 Aug;156(8):592-6. doi: 10.1007/s004310050671.
5
Recombinant human growth hormone replacement therapy and bone metabolism in children.
J Pediatr Endocrinol. 1993 Jan-Mar;6(1):33-7. doi: 10.1515/jpem.1993.6.1.33.
6
Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.1,25 - 二羟维生素D3和24,25 - 二羟维生素D3治疗期间尿毒症患者血清和尿液中反映骨转换的参数变化。
Miner Electrolyte Metab. 1993;19(2):78-85.
7
Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures.
Bone. 1990;11(2):81-6. doi: 10.1016/8756-3282(90)90054-3.
8
Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.生长激素长期治疗对生长激素缺乏症儿童骨骼和矿物质代谢的影响。
J Pediatr. 1993 Jan;122(1):37-45. doi: 10.1016/s0022-3476(05)83484-5.
9
Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.重组胰岛素样生长因子-I和生长激素对老年女性骨转换的影响。
J Bone Miner Res. 1995 Dec;10(12):1844-52. doi: 10.1002/jbmr.5650101203.
10
Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.重组胰岛素样生长因子-I(IGF-I)治疗期间及生长激素治疗期间,成年生长激素缺乏患者骨碱性磷酸酶同工型的不同反应。
J Bone Miner Res. 1997 Feb;12(2):210-20. doi: 10.1359/jbmr.1997.12.2.210.